Suppr超能文献

新型(-)-羟基柠檬酸钙/钾盐在体重控制方面的功效

Efficacy of a novel calcium/potassium salt of (-)-hydroxycitric acid in weight control.

作者信息

Preuss H G, Garis R I, Bramble J D, Bagchi D, Bagchi M, Rao C V S, Satyanarayana S

机构信息

Department of Physiology and Biophysics, Georgetown University Medical Center, Basic Science Building, Room 231 B, 4000 Reservoir Rd., N.W., Washington, DC 20057, USA.

出版信息

Int J Clin Pharmacol Res. 2005;25(3):133-44.

Abstract

The weight-loss efficacy of a novel, water-soluble, calcium-potassium salt of (-)-hydroxycitric acid (HCA-SX) was re-examined in 90 obese subjects (BMI: 30-50.8 kg/m2). We combined data from two previously reported randomized, double-blind, placebo-controlled clinical studies in order to achieve a better statistical evaluation based on a larger population. This re-examination of data also allowed us to reflect more intensely on various aspects of weight loss studies. Subjects were randomly divided into three groups: group A received a daily dose of HCA-SX 4, 667 mg (providing 2,800 mg HCA per day); group B was given a daily dose of a combination of HCA-SX 4,667 mg, niacin-bound chromium (NBC) 4 mg (providing 400 microg elemental chromium), and Gymnema sylvestre extract (GSE) 400 mg (providing 100 mg gymnemic acid); and group C received a placebo in three equally divided doses 30-60 min before each meal. All subjects were provided a 2,000 kcal diet/day and participated in a supervised walking program for 30 min/day, 5 days/week. Eighty-two subjects completed the study. At the end of 8 weeks, in group A, both body weight and BMI decreased by 5.4%, low-density lipoprotein and triglycerides levels were reduced by 12.9% and 6.9%, respectively, while high-density lipoprotein levels increased by 8.9%, serum leptin levels decreased by 38%, serotonin levels increased by 44.5% and urinary excretion of fat metabolites increased by 32-109%. Group B demonstrated similar beneficial changes, but generally to a greater extent. No significant adverse effects were observed. The combined results confirm that HCA-SX and, to a greater degree, the combination of HCA-SX plus NBC and GSE reduce body weight and BMI, suppress appetite, improve blood lipid profiles, increase serum leptin and serotonin levels and increase fat oxidation more than placebo. We conclude that dosage levels, timing of administration, subject compliance and bioavailability of HCA-SX significantly affect results and that when taken as directed, HCA-SX is a highly effective adjunct to healthy weight control.

摘要

在90名肥胖受试者(体重指数:30 - 50.8kg/m²)中重新检验了一种新型水溶性(-)-羟基柠檬酸钙钾盐(HCA - SX)的减肥效果。我们合并了两项先前报告的随机、双盲、安慰剂对照临床研究的数据,以便基于更大的样本量进行更好的统计评估。对数据的这种重新检验还使我们能够更深入地思考减肥研究的各个方面。受试者被随机分为三组:A组每日服用4667mg HCA - SX(每天提供2800mg HCA);B组每日服用4667mg HCA - SX、4mg烟酸铬(NBC,提供400μg元素铬)和400mg匙羹藤提取物(GSE,提供100mg匙羹藤酸)的组合;C组在每餐饭前30 - 60分钟分三次等量服用安慰剂。所有受试者每天摄入2000千卡的饮食,并参加一项每天监督进行30分钟、每周5天的步行计划。82名受试者完成了研究。在8周结束时,A组的体重和体重指数均下降了5.4%,低密度脂蛋白和甘油三酯水平分别降低了12.9%和6.9%,而高密度脂蛋白水平升高了8.9%,血清瘦素水平下降了38%,血清素水平升高了44.5%,脂肪代谢产物的尿排泄量增加了32 - 109%。B组表现出类似的有益变化,但总体程度更大。未观察到明显的不良反应。综合结果证实,HCA - SX以及在更大程度上HCA - SX加NBC和GSE的组合比安慰剂更能减轻体重和降低体重指数、抑制食欲、改善血脂谱、提高血清瘦素和血清素水平并增加脂肪氧化。我们得出结论,HCA - SX的剂量水平、给药时间、受试者依从性和生物利用度显著影响结果,并且按指示服用时,HCA - SX是健康体重控制的高效辅助手段。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验